Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers > Urologists

Dr. Jacob Rajfer, MD

Accepting New Patients

(10 Ratings)

Specializes in: Urology (Urinary Tract Disease)

Northwestern University, Feinberg School of Medicine (1972)

Professional interests include: low testosterone (male hypogonadism), benign prostatic hyperplasia (enlarged prostate), male infertility

10833 Le Conte Avenue
Los Angeles, CA 90024

(310) 435-4829

Dr. Jacob Rajfer, MD is an urologist in Los Angeles, CA specializing in urology (urinary tract disease). He graduated from Northwestern University, Feinberg School of Medicine in 1972 and has 53 years of experience. Dr. Jacob Rajfer, MD is affiliated with Regents of the University of California, UCLA Health and Ronald Reagan UCLA Medical Center.

Office Locations

Address:

10833 Le Conte Avenue
Los Angeles, CA 90024

Address:

200 Medical Plaza Suite 140
Los Angeles, CA 90095

Unable to locate address.

Address:

200 Suite 140
Los Angeles, CA 90095

Some issues Dr. Jacob Rajfer, MD can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

In The News (see more mentions in the news)

“The study "raises the question of whether people with borderline fertility may be affected in this manner," said Dr. Jacob Rajfer, a urologist at the UCLA Medical Center who specializes in male...”—"Male Fertility Drops During Summertime, Researchers Report", Los Angeles Times, September 2024

“That's why Dr. Jacob Rajfer, a professor of urology at University of California, Los Angeles, thinks that re-framing a man's health in terms of sexual health couldn't start early enough.”—"Erectile Dysfunction Is Not A Natural Part Of Aging -- It's A Sign Of Disease", Huff Post, April 2015

“Dr. Jacob Rajfer, a urologist at UCLA Medical School, says there's another reason the drugs are so profitable: Erectile dysfunction "happens to all men."”—"Love And Sex In The Time Of Viagra - 16 Years On", NPR, September 2014

blood draw	12
doctor visit	412
injections	110
lab tests	68
minimally invasive procedures	16
urologic procedures	165

**Ethnicity**
Non-Hispanic White	194
Black	28
Hispanic	47
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	150
From 75 to 84	75
85 and over	13
Less than 65	54

Hypertension	62
High Cholesterol	56
Stroke	0
Ischemic Heart Disease	41
Depression	16
Chronic Kidney Disease	29
Asthma	8
Osteoperosis	4
Atrial Fibrilation	11
Heart Failure	17
Chronic Obstructive Pulmonary Disease	7
Diabetes	38
Dementia	4
Cancer	26

doctor visit	368
injections	105
lab tests	46
minimally invasive procedures	16
urologic procedures	136

**Gender**
Male	279
Female	0

**Ethnicity**
Non-Hispanic White	203
Black	31
Hispanic	20
Asian	14
Other	11
Native American	0

**Age**
From 65 to 74	149
From 75 to 84	78
85 and over	15
Less than 65	37

Hypertension	58
High Cholesterol	53
Stroke	4
Ischemic Heart Disease	39
Depression	17
Chronic Kidney Disease	25
Asthma	8
Osteoperosis	4
Atrial Fibrilation	11
Heart Failure	14
Chronic Obstructive Pulmonary Disease	7
Diabetes	31
Dementia	4
Cancer	26

doctor visit	416
injections	148
lab tests	38
minimally invasive procedures	13
urologic procedures	157

**Gender**
Male	610
Female	0

**Ethnicity**
Non-Hispanic White	460
Black	58
Hispanic	32
Asian	0
Other	34
Native American	0

**Age**
From 65 to 74	364
From 75 to 84	150
85 and over	34
Less than 65	62

Hypertension	63
High Cholesterol	57
Stroke	0
Ischemic Heart Disease	46
Depression	15
Chronic Kidney Disease	22
Asthma	10
Osteoperosis	5
Atrial Fibrilation	11
Heart Failure	17
Chronic Obstructive Pulmonary Disease	7
Diabetes	35
Dementia	5
Cancer	31

doctor visit	225
injections	61
lab tests	24
urologic procedures	118

**Gender**
Male	182
Female	0

**Ethnicity**
Non-Hispanic White	144
Black	16
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	89
From 75 to 84	63
85 and over	15
Less than 65	15

Hypertension	67
High Cholesterol	60
Stroke	0
Ischemic Heart Disease	48
Depression	14
Chronic Kidney Disease	25
Asthma	11
Osteoperosis	0
Atrial Fibrilation	13
Heart Failure	15
Chronic Obstructive Pulmonary Disease	8
Diabetes	33
Dementia	0
Cancer	29

doctor visit	172
injections	32
lab tests	18
urologic procedures	74

**Gender**
Male	152
Female	0

**Ethnicity**
Non-Hispanic White	113
Black	12
Hispanic	13
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	75
From 75 to 84	51
85 and over	11
Less than 65	15

Hypertension	57
High Cholesterol	50
Stroke	0
Ischemic Heart Disease	42
Depression	15
Chronic Kidney Disease	32
Asthma	0
Osteoperosis	0
Atrial Fibrilation	11
Heart Failure	14
Chronic Obstructive Pulmonary Disease	0
Diabetes	36
Dementia	0
Cancer	20

blood draw	42
doctor visit	140
injections	17
lab tests	11
urologic procedures	58

**Gender**
Male	131
Female	0

**Ethnicity**
Non-Hispanic White	99
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	62
From 75 to 84	47
85 and over	0
Less than 65	0

Hypertension	64
High Cholesterol	64
Stroke	0
Ischemic Heart Disease	53
Depression	15
Chronic Kidney Disease	31
Asthma	0
Osteoperosis	0
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	11
Diabetes	35
Dementia	0
Cancer	16

**Gender**
Male	114
Female	0

**Ethnicity**
Non-Hispanic White	83
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	54
From 75 to 84	42
85 and over	0
Less than 65	0

Hypertension	60
High Cholesterol	56
Stroke	0
Ischemic Heart Disease	46
Depression	18
Chronic Kidney Disease	28
Asthma	11
Osteoperosis	0
Atrial Fibrilation	14
Heart Failure	19
Chronic Obstructive Pulmonary Disease	11
Diabetes	32
Dementia	10
Cancer	18

doctor visit	56
urologic procedures	13

**Gender**
Male	64
Female	0

**Ethnicity**
Non-Hispanic White	48
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	27
From 75 to 84	25
85 and over	0
Less than 65	0

Hypertension	66
High Cholesterol	63
Stroke	0
Ischemic Heart Disease	52
Depression	17
Chronic Kidney Disease	33
Asthma	0
Osteoperosis	0
Atrial Fibrilation	20
Heart Failure	23
Chronic Obstructive Pulmonary Disease	0
Diabetes	38
Dementia	0
Cancer	0

doctor visit	167
lab tests	11
urologic procedures	76

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Jacob Rajfer, MD for Medicare patients.

The highest averages for the top procedures that Dr. Jacob Rajfer, MD treated as an urologist in Los Angeles, CA were urologic procedures, injections, lab tests and blood draw.

blood draw	27
doctor visit	233
injections	69
lab tests	30
minimally invasive procedures	15
urologic procedures	96

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Jacob Rajfer, MD.

**Gender**
Female	0
Male	153

**Ethnicity**
Black / African American	14
Asian / Pacific Islander	1
Non-Hispanic White	134
Native American / Alaskan Native	0
Hispanic	11
Other	4

**Age**
85 and over	8
75 to 84	53
Less than 65	18
65 to 74	97

Average of Total of Conditions of Medicare patients treated by Dr. Jacob Rajfer, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Jacob Rajfer, MD treated were hypertension, high cholesterol, ischemic heart disease and diabetes.

Hypertension	49
High Cholesterol	45
Stroke	0
Ischemic Heart Disease	36
Depression	12
Chronic Kidney Disease	22
Asthma	4
Osteoporosis	1
Heart Failure	14
Chronic Obstructive Pulmonary Disease	5
Diabetes	27
Atrial Fibrillation	10
Cancer	16
Dementia	2

Education & Training

Dr. Jacob Rajfer, MD graduated from Northwestern University, Feinberg School of Medicine in 1972. He completed residency at Johns Hopkins University Affiliated Hospitals. He has a state license in California.

Medical School: Northwestern University, Feinberg School of Medicine (1972)

Residency: Johns Hopkins University Affiliated Hospitals (1978)

Licensed In: California

Affiliations & Hospitals

Dr. Jacob Rajfer, MD is associated with these hospitals and organizations:

Regents of the University of California

UCLA Health

Ronald Reagan UCLA Medical Center

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Jacob Rajfer, MD appears to accept the following insurance providers: Cigna, Private Healthcare Systems (PHCS), TRICARE, Aetna, Blue Shield of California, MultiPlan, UnitedHealthcare, Anthem, Medicare Advantage, Prime Health, First Health, HealthSmart, Centivo, Health Net of California, UFCM Health System and L.A. Care.

Insurance Accepted by Provider includes:

According to our sources, Dr. Jacob Rajfer, MD accepts the following insurance providers:

Cigna

Private Healthcare Systems (PHCS)

TRICARE

Aetna

Blue Shield of California

MultiPlan

UnitedHealthcare

Anthem

Medicare Advantage

Prime Health

First Health

HealthSmart

Centivo

Health Net of California

UFCM Health System

L.A. Care

Show More

Ratings & Reviews

Dr. Jacob Rajfer, MD has a high overall rating with an average of 4.05 out of 5 stars based on 10 ratings. We collect ratings and reviews of Dr. Jacob Rajfer, MD from all over the web to help you find the right in Los Angeles, CA.

4.05

Overall Rating

(10 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Jacob Rajfer, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Rochester Medical Corporation	$198 $198
Pfizer Inc.	$161 $161
Astellas Pharma US Inc	$34 Myrbetriq $34
C. R. Bard, Inc. & Subsidiaries	$26 Bard Urinary Drainage Bag $26
Allergan Inc.	$25 BOTOX $19	ACZONE $7

**Types of Payments**
Food and Beverage	$445

Research Payments

Dr. Jacob Rajfer, MD has received 36 research payments totaling $114,875.

Biography

Dr. Jacob Rajfer specializes in urology (urinary tract disease). He has a special interest in male infertility, benign prostatic hyperplasia (enlarged prostate), and low testosterone (male hypogonadism). Dr. Rajfer is affiliated with Regents of the University of California and Ronald Reagan UCLA Medical Center. After attending Northwestern University, Feinberg School of Medicine, he completed his residency training at a hospital affiliated with Johns Hopkins University. Dr. Rajfer's average rating from his patients is 4.0 stars (out of 5). He can take several insurance carriers, including Anthem, UnitedHealthcare, and Blue California. Distinctions awarded to Dr. Rajfer include: Top Doctors, Los Angeles Magazine; America's Top Doctors; and Best Doctors in America. He has an open panel in Los Angeles, CA according to UCLA Health.